- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04446923
Surgical Hand Antisepsis With Propan-ol-1 60% Per Rubbing and Scrubbing
July 20, 2020 updated by: César Calvo Lobo, Universidad Complutense de Madrid
Surgical Hand Antisepsis With Propan-ol-1 60% Per Rubbing and Scrubbing in Accordance With European Norm Regulation 12791
The present study evaluates the effects of to compare bactericidal efficacy using the reference antiseptic product propan-ol-1 60% using the hand rub method versus hand scrub method in order to test if pass the standard european norm 12791.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The investigators conducted a crossover clinical trial to evaluate the antiseptic effectiveness of preoperative surgical scrubbing using propan-ol-1 60% by rub and scrub.
Samples will be taken from the hands of each volunteer after a surgical hands antiseptic.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Madrid, Spain, 28040
- Ricardo Becerro de Bengoa Vallejo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participants without systemic pathologies, with healthy skin of the hands and short fingernails.
- They do not use substances with antibacterial action.
Exclusion Criteria:
- Taken antibiotics before 10 days of the intervention.
- Wear any jewellery on the hands.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Hand antisepsis by scrub
Hand antisepsis by scrub using propan-ol-1 60%
|
Surgical Hand scrubbing using P-1 of both hands using a sterile disposable surgical scrub brush with plastic bristles on one side and a foam sponge on the other side.
Other Names:
Surgical Hand rubbing using P-1 of both hands using a sterile disposable surgical scrub brush with plastic bristles on one side and a foam sponge on the other side.
Other Names:
|
Active Comparator: Hand antisepsis by rub
Hand antisepsis by rub using propan-ol-1 60%
|
Surgical Hand scrubbing using P-1 of both hands using a sterile disposable surgical scrub brush with plastic bristles on one side and a foam sponge on the other side.
Other Names:
Surgical Hand rubbing using P-1 of both hands using a sterile disposable surgical scrub brush with plastic bristles on one side and a foam sponge on the other side.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction of bacterial load immediately after hand scrub
Time Frame: Change from bacterial load at 5 minutes.
|
Participants will scrub the liquid vigorously from hand to the wrists according with the standard handrub procedure.
|
Change from bacterial load at 5 minutes.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction of bacterial load after 3 hours of hand scrub
Time Frame: Change from bacterial load at 3 hours.
|
Participants will scrub the liquid vigorously from hand to the wrists according with the standard handrub procedure after 3 hours
|
Change from bacterial load at 3 hours.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ricardo Becerro de Bengoa Vallejo, PhD, Ricardo Becerro de Bengoa Vallejo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 28, 2020
Primary Completion (Actual)
July 18, 2020
Study Completion (Actual)
July 20, 2020
Study Registration Dates
First Submitted
June 22, 2020
First Submitted That Met QC Criteria
June 22, 2020
First Posted (Actual)
June 25, 2020
Study Record Updates
Last Update Posted (Actual)
July 21, 2020
Last Update Submitted That Met QC Criteria
July 20, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Infections
- Postoperative Complications
- Wound Infection
- Surgical Wound Infection
- Skin Diseases
- Physiological Effects of Drugs
- Adrenergic beta-Antagonists
- Adrenergic Antagonists
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Antihypertensive Agents
- Vasodilator Agents
- Propranolol
Other Study ID Numbers
- RICBEC1-UCM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
A number will be assigned to each participant
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Diseases
-
West Virginia UniversityMary Babb Randolph Cancer Center at West Virginia University Hospitals; West...RecruitingSkin Cancer | Skin Lesion | Skin Melanoma | Tumor SkinUnited States
-
R2 DermatologyCompleted
-
TCI Co., Ltd.Completed
-
Access Business GroupClinical Research LaboratoriesCompleted
-
R2 DermatologyRecruitingSkin LesionUnited States
-
TCI Co., Ltd.Completed
Clinical Trials on Hand antisepsis by scrub
-
Istanbul UniversityNot yet recruitingScleroderma, Systemic | Rehabilitation | Physiotherapy | Scleroderma | Hand Rheumatism | Scleroderma Associated Digital UlcerTurkey
-
Fondazione Salvatore MaugeriCompletedStroke | Upper Extremity Hemiplegia | Disorder of Hand
-
Istanbul UniversityIstanbul University - Cerrahpasa (IUC)CompletedSystemic Sclerosis | Rehabilitation | Physiotherapy | Scleroderma | Hand RheumatismTurkey
-
EyeQue Corp.CompletedRefractive Errors | AstigmatismUnited States
-
EyeQue Corp.Eye Boutique OptometryCompleted
-
Centro Ortopedico y Quirurgico del PieUnknown
-
Centro Ortopedico y Quirurgico del PieCompleted
-
Centro Ortopedico y Quirurgico del PieCompleted
-
University of TromsoSorlandet Hospital HFNot yet recruiting
-
CHU de ReimsUnknownPancreatic Cancer | Malnutrition | Sarcopenia | Liver CancerFrance